Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | DNA | Class A Common Stock | Sale | -$298K | -152K | -1.12% | $1.96 | 13.4M | Feb 7, 2023 | Direct | F1 |
transaction | DNA | Class A Common Stock | Sale | -$243K | -129K | -0.96% | $1.88 | 13.3M | Feb 8, 2023 | Direct | F1 |
transaction | DNA | Class A Common Stock | Sale | -$187K | -100K | -0.75% | $1.87 | 13.2M | Feb 8, 2023 | Direct | F2, F3 |
Id | Content |
---|---|
F1 | Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. |
F2 | The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. |
F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.80 to $1.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
CEO & Founder